In our study, concurrent treatment of CIS with QUE in either free or nanoform induced elevation of the testicular function and histological structure, confirmed by elevation of testosterone, IL-10 levels, and Johnsen scores, in addition to a reduction in Cosentino grade. The gene discussed is IL10; the disease is in situ carcinoma.